| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2001 | US6218432 Diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218425 Useful in the treatment of estrogen-related disorders such as osteoporosis, hyperlipidemia, estrogen-related breast cancer, uterine fibrosis, endometriosis, and restenosis |
| 04/17/2001 | US6218424 Heterocyclic ketone and thioester compounds and uses |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218421 Administering an effective, non-toxic amount of ropinirole or pharmaceutically acceptable salt or solvate thereof to a human for promoting cessation of smoking tobacco |
| 04/17/2001 | US6218420 For therapy and prophylaxis of alimentary overloads in conditions of elevated body nitrogen requirements, without causing calcium losses |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218414 Administering an effective amount of an angiotensin ii antagonist and a benzofuran derivative with antiarrhythmic activity for therapy of cardiovascular complaints |
| 04/17/2001 | US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218411 Administering potassium channel activator for therapy of diabetic complication in patient suffering from diabetes mellitus |
| 04/17/2001 | US6218410 Medicines comprising Rho kinase inhibitor |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218405 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 04/17/2001 | US6218403 Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor |
| 04/17/2001 | US6218402 Antagonizing the serotonin 5ht3 receptor with a pyrrolo quinoline derivative |
| 04/17/2001 | US6218400 Treating angina, hypertension, pulmonary disease, vascular disorders, stroke, bronchitis, asthma, rhinitis, glaucoma, sexual disorders, and disorders of gut motility |
| 04/17/2001 | US6218399 Modifying the 20 position of camptothecin to form a compound which is low toxicity used in cancer therapy |
| 04/17/2001 | US6218398 Nocathiacin antibiotics |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | US6218396 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 04/17/2001 | US6218395 For relieving psychic and somatic symptoms of anxiety disorder or adjustment disorder |
| 04/17/2001 | US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines |
| 04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/17/2001 | US6218391 Triazinones and derivatives thereof |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218388 Therapy of protein tyrosine kinase mediated cancer, atherosclerosis, restenosis, and psoriasis by administering benzimidazole derivative |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6218384 3-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 04/17/2001 | US6218383 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | US6218380 Pharmaceutical compositions |
| 04/17/2001 | US6218379 As antibacterial |
| 04/17/2001 | US6218378 For therapy or inhibition of ovarian tumors, cervical tumors, lung cancer and melanoma |
| 04/17/2001 | US6218377 Methods for the administration of amifostine and related compounds |
| 04/17/2001 | US6218375 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin and method |
| 04/17/2001 | US6218373 Formulations containing hyaluronic acid |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | US6218369 Administering flavanolignane selected from silymarin, silybin, silidianin, silicristin, dehydrosilybin, phospholipid complex of one of these flavanolignanes, and mixtures, in combination with antitumor agent |
| 04/17/2001 | US6218368 Long term treatment of age related blindness via administering macrolides such as erythromycin, rifamycin and derivatives, or metronidazole |
| 04/17/2001 | US6218366 Method for raising the hypoxic threshold |
| 04/17/2001 | US6218365 Serine protease inhibitors |
| 04/17/2001 | US6218361 Administering anti-angiogenic agent selected from consisting of agm 1470 and tnp-470 for inhibiting chronic allograft rejection with an organ transplant |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6218192 Method and composition for treatment of headache using magnesium |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6218133 Materials and methods for detection and treatment of immune system dysfunctions |
| 04/17/2001 | US6218132 Activating t-cells with antigen to cause expansion, reactivating with antigen and antigen presenting cells to induce secretion of soluble factor, then detecting by capturing factor on solid support |
| 04/17/2001 | US6218100 Eliminating viral disease transmission through blood products via said compositions which have ability to inactivate pathogens in presence of ultaviolet light without effecting blood product functioning or exhibiting mutagenicity |
| 04/17/2001 | US6217914 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 04/17/2001 | US6217913 Cosmetic compositions with gorgonian extract |
| 04/17/2001 | US6217907 Directly compressible high load acetaminophen formulations |
| 04/17/2001 | US6217904 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant |
| 04/17/2001 | US6217900 Vesicular complexes and methods of making and using the same |
| 04/17/2001 | US6217898 Pharmaceutical composition comprising carnitine or alkanoyl L-carnitine, for the prevention and treatment of diseases brought about by lipid metabolism disorders |
| 04/17/2001 | US6217897 Anhydrous spreadable mucoadhesive |
| 04/17/2001 | US6217895 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 04/17/2001 | US6217893 Sustained-release compositions and method for preparing same |
| 04/17/2001 | US6217887 Leave-on antimicrobial compositions which provide improved immediate germ reduction |
| 04/17/2001 | US6217877 Extraction using water miscible solvent |
| 04/17/2001 | US6217875 Inhibitors of lipoxygenase |
| 04/17/2001 | US6217866 Antitumor agents mixture |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217851 Mixture of calcium, arginine and bicarbonate |
| 04/17/2001 | US6216283 Elephant nose plunger |
| 04/17/2001 | CA2220018C Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/17/2001 | CA2195863C Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby |
| 04/17/2001 | CA2185192C Novel substituted 2,2,-dimethyl-w-phenoxyalcanoic acids and esters; process for preparing the same and pharmaceutical compositions containing them |
| 04/17/2001 | CA2179396C Tetrahydrofuran antifungals |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/17/2001 | CA2080475C Neuroprotective indolone and related derivatives |
| 04/17/2001 | CA2072106C Cephalosporin compounds and method for producing them |
| 04/17/2001 | CA2071483C Oligonucleotide analogs with novel linkages |
| 04/17/2001 | CA2055493C Antineoplastic solution and method for treating neoplasms |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/17/2001 | CA2024255C A novel pharmaceutical composition having antitumor activity and preparation for its manufacture |
| 04/17/2001 | CA2010963C Process for the preparation of lactam derivatives |
| 04/17/2001 | CA2010639C Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones |
| 04/15/2001 | CA2301491A1 Novel 7-aminopyrido [2,3-d]pyrimidine derivatives |
| 04/15/2001 | CA2286442A1 Compositions for increasing the concentration of cannabinoids as vasodilators and cardioprotectors againts ischaemia |
| 04/12/2001 | WO2001025489A2 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025469A2 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |